Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.91 +0.72%   SPY: 135.36 +0.13%
Quote Spy PPHM NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Peregrine Pharmaceuticals (PPHM)

@ 4:00 PM
Click the portfolio to add PPHM:
Close [X]
+ Add PPHM to Portfolio
  
  Last Trade: $1.04 -0.01 (-0.95%)
  Volume: 1,558,286 117% of avg daily volume
       
  Avg Volume: 1,330,251
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 1.02 - 1.07
  Open: 1.06
  Previous Close: 1.05
  52-wk Range: 0.85 - 2.74
  Market Cap: 90.9M
  P/E: -1.9
  Div Yield: $0.00 (0.00%)
Indexes
Cancer Stocks (-0.9%)
Spy PPHM

? Pro holders
? Member holders
? Items submitted
Additional PPHM resources



Customize Links
To see which Pros and tickerspy members own PPHM Sign up now
Latest PPHM Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Peregrine Pharmaceuticals Reports Second Quarter 2012 Financial Results and Recent Developments
PPHM  
Linked by marketwire - December 12, 04:05PM from (www2.marketwire.com)
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Is This Drug About to Cure Cancer?
PFE  PPHM  XLV  
Linked by Benzinga.com - December 06, 02:32PM from (www.benzinga.com)
Peregrine Pharmaceuticals (NASDAQ: PPHM) has traditionally been an unknown biopharma player. Until now, that is. Peregrine  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Peregrine to Report Second Quarter Fiscal Year 2012 Financial Results After Market on December 12, 2011
PPHM  
Linked by marketwire - December 05, 08:00AM from (www2.marketwire.com)
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2012 Financial Results and Recent Developments
PPHM  
Linked by marketwire - September 09, 08:00AM from (www2.marketwire.com)
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Peregrine to Report First Quarter Fiscal Year 2012 Financial Results Before Market on September 9, 2011
PPHM  
Linked by marketwire - September 02, 09:00AM from (www2.marketwire.com)
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Peregrine Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2011 Financial Results and Recent Developments
PPHM  
Linked by marketwire - July 14, 04:00PM from (www2.marketwire.com)
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Peregrine to Report Fourth Quarter and Fiscal Year 2011 Financial Results After Market Close on July 14, 2011
PPHM  
Linked by marketwire - July 07, 08:00AM from (www2.marketwire.com)
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Peregrine Appoints Jeffrey Masten as Vice President, Quality as Company Advances Phase II Clinical Programs
PPHM  
Linked by marketwire - May 31, 08:00AM from (www2.marketwire.com)
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Lots of ASCO abstract links
PFE  PPHM  NAVB  IMGN  INCY  GNTA  ARIA  NKTR  EXEL  ONXX  SGEN  SNSS  AGEN  ARRY  YMI  THLD  AVEO  ECYT  
Linked by Chasing the Alpha - May 18, 07:55PM from (www.chasingthealpha.com)
I don't have much time to discuss them all, but I starred the more important ones. Keep in mind, some of these only have  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource